Original Research

Accepted on 04 Nov 2024

The antipsychotic drug lurasidone inhibits coronaviruses by affecting multiple targets

in Antibiotic Resistance and New Antimicrobial drugs

Sara Baroni
Tea Carletti
Manuela Donalisio
Irene Arduino
Irene Cazzaniga
Toni Giorgino
Francesca Esposito
Alessia Porta
Luisa Diomede
Ada De Luigi

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1487604

Review

Published on 01 Nov 2024

Artificial intelligence in predicting pathogenic microorganisms’ antimicrobial resistance: challenges, progress, and prospects

in Antibiotic Resistance and New Antimicrobial drugs

Yan Li

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1482186

375 views

Original Research

Accepted on 28 Oct 2024

Terpenoids as Principal Bioactive Compound of Cissampelos oppositifolia Essential Oils: Enhancing Synergistic Efficacy with Conventional Antibiotics

in Antibiotic Resistance and New Antimicrobial drugs

Kexin Zhao
Yurong Jiang
Kamal Dev
Xin He
Xinli Pang
Vipasha Sharma

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1481656

163 views

Original Research

Published on 24 Oct 2024

Phenotypic and genetic characterization of daptomycin non-susceptible Staphylococcus aureus strains selected by adaptive laboratory evolution

in Antibiotic Resistance and New Antimicrobial drugs

Xiaocui Wu
Ying Zhou
Yongpeng Shang
Wang Bingjie
Yanghua Xiao

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1453233

520 views

Original Research

Published on 24 Oct 2024

Prevalence and clinical significance of the genotypic carriage among ESBL phenotype-negative Escherichia coli and Klebsiella pneumoniae clinical isolates in bacteremia: a study in a Malaysian tertiary center

in Antibiotic Resistance and New Antimicrobial drugs

Isa Naina Mohamed
Toh Leong Tan
Petrick Periyasamy
Hui-min Neoh
Chee Lan Lau

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1429830

659 views

Original Research

Published on 22 Oct 2024

Novel antimicrobial coating for hernia meshes

in Antibiotic Resistance and New Antimicrobial drugs

Christian Fölsch
Débora Coraça-Huber
Klaus-Dieter Prof. Dr. Kühn

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1383680

616 views

Original Research

Published on 16 Oct 2024

Assessment of community-acquired urinary tract infections treatment in the emergency department: a retrospective study

in Antibiotic Resistance and New Antimicrobial drugs

Racha Ibrahim
Marie Ange Ghaleb

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1433597

630 views

Original Research

Published on 15 Oct 2024

Deciphering the killing mechanisms of potassium iodide in combination with antimicrobial photodynamic therapy against cross-kingdom biofilm

in Antibiotic Resistance and New Antimicrobial drugs

Xiaojing Huang
Shan Huang
Yijun Li

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1444764

636 views

Original Research

Published on 15 Oct 2024

ProcCluster® and procaine hydrochloride inhibit the growth of Aspergillus species and exert antimicrobial properties during coinfection with influenza A viruses and A. fumigatus in vitro

in Antibiotic Resistance and New Antimicrobial drugs

Christina Ehrhardt
Bettina Löffler
Axel Brakhage
Josefine Schroeder
Sarah König

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1445428

736 views

Review

Accepted on 14 Oct 2024

The tigecycline resistance mechanisms in Gram-negative bacilli

in Antibiotic Resistance and New Antimicrobial drugs

Zhiren Wang
Henan Li

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1471469

100 views

Brief Research Report

Accepted on 09 Oct 2024

Resistome in the indoor dust samples from workplaces and households: a pilot study

in Antibiotic Resistance and New Antimicrobial drugs

Eva Klvanova
Petra Videnska
Vojtech Barton
Jan Bohm
Petra Splichalova
Viktorie Koksova
Milan Urik
Barbara Lanickova
Roman Prokes
Eva Budinska

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1484100

221 views

Original Research

Accepted on 04 Oct 2024

Epitope-Based Therapeutic Targets in HCV Genotype 1 Non-Structural Proteins: A Novel Strategy to Combat Emerging Drug Resistance

in Antibiotic Resistance and New Antimicrobial drugs

Mireayi Tudi
Adili Sawuti
Maimaitituerhong Abuduresuli
Chao Wu
Xiaoyu Chen
Gulimire Ailimu
Kuerbannisa Wulayin
Maimaitiaili Tuerxun

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1480987

271 views

Original Research

Published on 04 Oct 2024

Characterization of four novel bacteriophages targeting multi-drug resistant Klebsiella pneumoniae strains of sequence type 147 and 307

in Antibiotic Resistance and New Antimicrobial drugs

Marco Maria D'Andrea
Maurizio Fraziano
Gian Maria Rossolini
Claudio Lubello
Pietro Lupetti
Mariangela Gentile
Gustavo Di Lallo
Marco Coppi
Alberto Antonelli
Noemi Poerio

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1473668

990 views

Original Research

Published on 01 Oct 2024

Distribution characteristics of integrons and correlation analysis of antibiotic resistance in urine isolated Enterobacter cloacae

in Antibiotic Resistance and New Antimicrobial drugs

Min Jiang
Xuedan Qiu

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1462742

389 views

Opinion

Published on 01 Oct 2024

Lipoprotein transport system Lol may be a selective target for Gram-negative bacteria

in Antibiotic Resistance and New Antimicrobial drugs

SIFAN GUO
Zhibo Wang
Ying Cai
YANG QIANG

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1463316

408 views

Original Research

Published on 01 Oct 2024

In silico testing to identify compounds that inhibit ClfA and ClfB binding to the host for the formulation of future drugs against Staphylococcus aureus colonization and infection

in Antibiotic Resistance and New Antimicrobial drugs

SABIHA FATIMA
Suhail Akhtar
Abdul Malik
Dr.Balagopalan Unni
Dr Rajpal Singh Kashyap
Minakshi Bhattacharjee
Shila Singh

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1422500

379 views

Navigation group

Articles

The antipsychotic drug lurasidone inhibits coronaviruses by affecting multiple targets

Artificial intelligence in predicting pathogenic microorganisms’ antimicrobial resistance: challenges, progress, and prospects

Terpenoids as Principal Bioactive Compound of Cissampelos oppositifolia Essential Oils: Enhancing Synergistic Efficacy with Conventional Antibiotics

Phenotypic and genetic characterization of daptomycin non-susceptible Staphylococcus aureus strains selected by adaptive laboratory evolution

Prevalence and clinical significance of the genotypic carriage among ESBL phenotype-negative Escherichia coli and Klebsiella pneumoniae clinical isolates in bacteremia: a study in a Malaysian tertiary center

Novel antimicrobial coating for hernia meshes

Assessment of community-acquired urinary tract infections treatment in the emergency department: a retrospective study

Deciphering the killing mechanisms of potassium iodide in combination with antimicrobial photodynamic therapy against cross-kingdom biofilm

ProcCluster® and procaine hydrochloride inhibit the growth of Aspergillus species and exert antimicrobial properties during coinfection with influenza A viruses and A. fumigatus in vitro

The tigecycline resistance mechanisms in Gram-negative bacilli

Resistome in the indoor dust samples from workplaces and households: a pilot study

Epitope-Based Therapeutic Targets in HCV Genotype 1 Non-Structural Proteins: A Novel Strategy to Combat Emerging Drug Resistance

Characterization of four novel bacteriophages targeting multi-drug resistant Klebsiella pneumoniae strains of sequence type 147 and 307

Distribution characteristics of integrons and correlation analysis of antibiotic resistance in urine isolated Enterobacter cloacae

Lipoprotein transport system Lol may be a selective target for Gram-negative bacteria

In silico testing to identify compounds that inhibit ClfA and ClfB binding to the host for the formulation of future drugs against Staphylococcus aureus colonization and infection